1. Home
  2. SYRE vs PLAB Comparison

SYRE vs PLAB Comparison

Compare SYRE & PLAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SYRE
  • PLAB
  • Stock Information
  • Founded
  • SYRE 2013
  • PLAB 1969
  • Country
  • SYRE United States
  • PLAB United States
  • Employees
  • SYRE N/A
  • PLAB N/A
  • Industry
  • SYRE Biotechnology: Pharmaceutical Preparations
  • PLAB Semiconductors
  • Sector
  • SYRE Health Care
  • PLAB Technology
  • Exchange
  • SYRE Nasdaq
  • PLAB Nasdaq
  • Market Cap
  • SYRE 1.1B
  • PLAB 1.2B
  • IPO Year
  • SYRE 2016
  • PLAB 1987
  • Fundamental
  • Price
  • SYRE $14.82
  • PLAB $22.91
  • Analyst Decision
  • SYRE Strong Buy
  • PLAB Strong Buy
  • Analyst Count
  • SYRE 5
  • PLAB 2
  • Target Price
  • SYRE $61.25
  • PLAB $31.00
  • AVG Volume (30 Days)
  • SYRE 485.5K
  • PLAB 725.8K
  • Earning Date
  • SYRE 11-06-2025
  • PLAB 08-27-2025
  • Dividend Yield
  • SYRE N/A
  • PLAB N/A
  • EPS Growth
  • SYRE N/A
  • PLAB N/A
  • EPS
  • SYRE N/A
  • PLAB 1.77
  • Revenue
  • SYRE N/A
  • PLAB $856,152,000.00
  • Revenue This Year
  • SYRE N/A
  • PLAB N/A
  • Revenue Next Year
  • SYRE N/A
  • PLAB $5.06
  • P/E Ratio
  • SYRE N/A
  • PLAB $12.93
  • Revenue Growth
  • SYRE N/A
  • PLAB N/A
  • 52 Week Low
  • SYRE $10.91
  • PLAB $16.46
  • 52 Week High
  • SYRE $40.26
  • PLAB $31.60
  • Technical
  • Relative Strength Index (RSI)
  • SYRE 34.55
  • PLAB 59.18
  • Support Level
  • SYRE $15.80
  • PLAB $21.86
  • Resistance Level
  • SYRE $17.58
  • PLAB $22.87
  • Average True Range (ATR)
  • SYRE 0.74
  • PLAB 0.77
  • MACD
  • SYRE -0.24
  • PLAB -0.04
  • Stochastic Oscillator
  • SYRE 5.32
  • PLAB 41.64

About SYRE Spyre Therapeutics Inc.

Spyre Therapeutics Inc is a biotechnology company that aims to create the next-generation of inflammatory bowel disease (IBD) products by combining antibody engineering, rational therapeutic combinations, and precision medicine approaches for patient selection. IBD is a chronic condition characterized by inflammation within the gastrointestinal tract, including two main disorders which are UC and CD. It has a single reportable segment, which is the development of biopharmaceutical products for the treatment of patients with IBD and other immune-mediated disease.

About PLAB Photronics Inc.

Photronics Inc is a U.S.-based company that is principally engaged in manufacturing photomasks. The photomasks are photographic quartz or glass plates that contain microscopic images of electronic circuits that are used as a component in the manufacture of integrated circuits and flat-panel displays. The revenue from products designed for integrated circuits production accounts for the majority of total revenue, with the rest derived from products for flat-panel display production. The company's assets are located in Taiwan, Korea, and the United States. It generates revenue world-wide, including in the United States, Europe, Taiwan, Korea, China, and elsewhere in Asia, with Taiwan contributing the majority of total revenue.

Share on Social Networks: